NCT00359788 - A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. | Biotech Hunter

Enrollment

349

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

April 30, 2008

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

tiotropium

DRUG

Combivent (Ipratropium/Albuterol)

Trial Locations (31)

205.325.904 Boehringer Ingelheim Investigational Site, Birmingham

205.325.925 Boehringer Ingelheim Investigational Site, Phoenix

205.325.909 Boehringer Ingelheim Investigational Site, Tucson

205.325.912 Boehringer Ingelheim Investigational Site, Long Beach

205.325.911 Boehringer Ingelheim Investigational Site, Palo Alto

205.325.935 Boehringer Ingelheim Investigational Site, Fort Collins

205.325.903 Boehringer Ingelheim Investigational Site, West Haven

205.325.905 Boehringer Ingelheim Investigational Site, Bay Pines

205.325.922 Boehringer Ingelheim Investigational Site, Decatur

205.325.907 Boehringer Ingelheim Investigational Site, North Chicago

205.325.928 Boehringer Ingelheim Investigational Site, Indiananapolis

205.325.923 Boehringer Ingelheim Investigational Site, Wichita

205.325.902 Boehringer Ingelheim Investigational Site, Baltimore

205.325.908 Boehringer Ingelheim Investigational Site, Boston

205.325.920 Boehringer Ingelheim Investigational Site, Ann Arbor

205.325.932 Boehringer Ingelheim Investigational Site, Ann Arbor

205.325.915 Boehringer Ingelheim Investigational Site, Minneapolis

205.325.914 Boehringer Ingelheim Investigational Site, Kansas City

205.325.910 Boehringer Ingelheim Investigational Site, Reno

205.325.924 Boehringer Ingelheim Investigational Site, East Orange

205.325.921 Boehringer Ingelheim Investigational Site, Brooklyn

205.325.917 Boehringer Ingelheim Investigational Site, Buffalo

205.325.926 Boehringer Ingelheim Investigational Site, Cincinnati

205.325.901 Boehringer Ingelheim Investigational Site, Cleveland

205.325.931 Boehringer Ingelheim Investigational Site, Portland

205.325.929 Boehringer Ingelheim Investigational Site, Providence

205.325.936 Boehringer Ingelheim Investigational Site, Greenville

205.325.918 Boehringer Ingelheim Investigational Site, Houston

205.325.927 Boehringer Ingelheim Investigational Site, San Antonio

205.325.919 Boehringer Ingelheim Investigational Site, Salt Lake City

205.325.906 Boehringer Ingelheim Investigational Site, Richmond